Insider Selling: Neogen Co. (NASDAQ:NEOG) Director Sells $303,500.00 in Stock

Neogen Co. (NASDAQ:NEOG) Director James L. Herbert sold 5,000 shares of the business’s stock in a transaction on Monday, July 8th. The stock was sold at an average price of $60.70, for a total transaction of $303,500.00. Following the completion of the transaction, the director now owns 631,484 shares of the company’s stock, valued at approximately $38,331,078.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

NASDAQ:NEOG opened at $63.00 on Friday. The stock has a fifty day simple moving average of $59.76. The firm has a market capitalization of $3.23 billion, a P/E ratio of 52.07, a price-to-earnings-growth ratio of 5.09 and a beta of 1.34. Neogen Co. has a 52 week low of $50.60 and a 52 week high of $97.38.

Several equities analysts have commented on NEOG shares. BidaskClub downgraded shares of Virtu Financial from a “sell” rating to a “strong sell” rating in a research note on Wednesday, June 12th. Craig Hallum downgraded shares of PFSweb from a “buy” rating to a “hold” rating in a research note on Tuesday, March 19th. Zacks Investment Research downgraded shares of Gold Resource from a “hold” rating to a “sell” rating in a research note on Friday, June 21st. Finally, Guggenheim restated a “buy” rating and issued a $95.00 price target (up previously from $90.00) on shares of VF in a research note on Thursday, May 23rd. One analyst has rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $65.38.

Several large investors have recently bought and sold shares of the business. Creative Planning lifted its position in shares of Neogen by 2.4% during the 1st quarter. Creative Planning now owns 7,554 shares of the company’s stock worth $434,000 after purchasing an additional 174 shares during the last quarter. Arizona State Retirement System lifted its position in shares of Neogen by 0.3% during the 1st quarter. Arizona State Retirement System now owns 80,344 shares of the company’s stock worth $4,611,000 after purchasing an additional 272 shares during the last quarter. Manchester Capital Management LLC lifted its position in shares of Neogen by 105.6% during the 1st quarter. Manchester Capital Management LLC now owns 590 shares of the company’s stock worth $34,000 after purchasing an additional 303 shares during the last quarter. Captrust Financial Advisors lifted its position in shares of Neogen by 47.0% during the 4th quarter. Captrust Financial Advisors now owns 970 shares of the company’s stock worth $55,000 after purchasing an additional 310 shares during the last quarter. Finally, McCollum Christoferson Group LLC lifted its position in shares of Neogen by 0.3% during the 1st quarter. McCollum Christoferson Group LLC now owns 124,921 shares of the company’s stock worth $7,169,000 after purchasing an additional 334 shares during the last quarter. Institutional investors and hedge funds own 90.10% of the company’s stock.

Neogen Company Profile

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment primarily offers diagnostic test kits and complementary to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells.

Further Reading: What is a put option?

Insider Buying and Selling by Quarter for Neogen (NASDAQ:NEOG)

Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.